Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Salicylate protects against the ototoxic and nephrotoxic side effects of cisplatin in rats

Aug. 20, 2002

Phase I solid tumor trial initiated for KSP inhibitor

Aug. 20, 2002

ARC enters research agreement with McGill University for antisense oligonucleotide therapeutics

Aug. 20, 2002

Interferon inducers described by Sumitomo and Japan Energy at ACS meeting

Aug. 19, 2002

Enrollment initiated in phase III atamestane trial

Aug. 19, 2002

Viragen and U. of Miami collaborate on immune enhancing drug for cancer

Aug. 19, 2002

Novel EGFR inhibitors in early development at Boehringer Ingelheim

Aug. 14, 2002

FDA approves Eloxatin for advanced colorectal cancer

Aug. 14, 2002

ANO-2, a novel cyclic peroxide, shows multifunctional antiangiogenic and antitumor activity

Aug. 14, 2002

VNP-40101M enters phase I trial in leukemia

Aug. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...